Updated Jul 16, 2026 · Last SEC filing 2026-06-30
Benitec Biopharma Inc. (BNTC) has filed 2 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-30. 2 Form 8-K material event filings were reported by BNTC in the last 90 days. InsiderAlpha tracks every BNTC SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001808898 |
|---|
| Form 4 filings (90d) | 2 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-06-30 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| BUCHI J KEVIN | Insider | G — Bona-fide gift | 51.8K | $0.00 | — | SEC | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | P — Open-market purchase | 65.8K | $13.44 | $884K | SEC | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | P — Open-market purchase | 11.6K | $13.44 | $156K | SEC | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | P — Open-market purchase | 14.3K | $13.10 | $188K | SEC | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | P — Open-market purchase | 2.5K | $13.10 | $33K | SEC | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | P — Open-market purchase | 7.4K | $12.85 | $95K | SEC | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | P — Open-market purchase | 42.6K | $12.85 | $547K | SEC | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | P — Open-market purchase | 2.9K | $12.08 | $35K | SEC | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | P — Open-market purchase | 16.6K | $12.08 | $201K | SEC | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | P — Open-market purchase | 2.4K | $11.48 | $28K | SEC | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | P — Open-market purchase | 13.9K | $11.48 | $160K | SEC | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | P — Open-market purchase | 1.5K | $11.24 | $17K | SEC | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | P — Open-market purchase | 8.7K | $11.24 | $98K | SEC | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | P — Open-market purchase | 2.3K | $11.25 | $26K | SEC | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Insider | P — Open-market purchase | 17.7K | $11.25 | $199K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Benitec Biopharma Inc. (BNTC). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| BUCHI J KEVIN | 1 | — |
| Friedman David Matthew | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in BNTC insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live BNTC dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.